Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death

Despite the available chemotherapy and treatment, leukemia remains a difficult disease to cure due to frequent relapses after treatment. Among the heterogeneous leukemic cells, a rare population referred as the leukemic stem cell (LSC), is thought to be responsible for relapses and drug resistance....

Full description

Bibliographic Details
Main Authors: Qian Feng, Wa Seng Leong, Liang Liu, Wai-In Chan
Format: Article
Language:English
Published: MDPI AG 2016-04-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/21/4/534
_version_ 1811194113695940608
author Qian Feng
Wa Seng Leong
Liang Liu
Wai-In Chan
author_facet Qian Feng
Wa Seng Leong
Liang Liu
Wai-In Chan
author_sort Qian Feng
collection DOAJ
description Despite the available chemotherapy and treatment, leukemia remains a difficult disease to cure due to frequent relapses after treatment. Among the heterogeneous leukemic cells, a rare population referred as the leukemic stem cell (LSC), is thought to be responsible for relapses and drug resistance. Cardiac glycosides (CGs) have been used in treating heart failure despite its toxicity. Recently, increasing evidence has demonstrated its new usage as a potential anti-cancer drug. Ouabain, one of the CGs, specifically targeted CD34+CD38− leukemic stem-like cells, but not the more mature CD34+CD38+ leukemic cells, making this type of compounds a potential treatment for leukemia. In search of other potential anti-leukemia CGs, we found that Peruvoside, a less studied CG, is more effective than Ouabain and Digitoxin at inducing cell death in primitive myeloid leukemia cells without obvious cytotoxicity on normal blood cells. Similar to Ouabain and Digitoxin, Peruvoside also caused cell cycle arrest at G2/M stage. It up-regulates CDKN1A expression and activated the cleavage of Caspase 3, 8 and PARP, resulting in apoptosis. Thus, Peruvoside showed potent anti-leukemia effect, which may serve as a new anti-leukemia agent in the future.
first_indexed 2024-04-12T00:20:33Z
format Article
id doaj.art-c293e4c03ed34fb48d4c7d3f56b265e9
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-04-12T00:20:33Z
publishDate 2016-04-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-c293e4c03ed34fb48d4c7d3f56b265e92022-12-22T03:55:44ZengMDPI AGMolecules1420-30492016-04-0121453410.3390/molecules21040534molecules21040534Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell DeathQian Feng0Wa Seng Leong1Liang Liu2Wai-In Chan3State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, ChinaDespite the available chemotherapy and treatment, leukemia remains a difficult disease to cure due to frequent relapses after treatment. Among the heterogeneous leukemic cells, a rare population referred as the leukemic stem cell (LSC), is thought to be responsible for relapses and drug resistance. Cardiac glycosides (CGs) have been used in treating heart failure despite its toxicity. Recently, increasing evidence has demonstrated its new usage as a potential anti-cancer drug. Ouabain, one of the CGs, specifically targeted CD34+CD38− leukemic stem-like cells, but not the more mature CD34+CD38+ leukemic cells, making this type of compounds a potential treatment for leukemia. In search of other potential anti-leukemia CGs, we found that Peruvoside, a less studied CG, is more effective than Ouabain and Digitoxin at inducing cell death in primitive myeloid leukemia cells without obvious cytotoxicity on normal blood cells. Similar to Ouabain and Digitoxin, Peruvoside also caused cell cycle arrest at G2/M stage. It up-regulates CDKN1A expression and activated the cleavage of Caspase 3, 8 and PARP, resulting in apoptosis. Thus, Peruvoside showed potent anti-leukemia effect, which may serve as a new anti-leukemia agent in the future.http://www.mdpi.com/1420-3049/21/4/534cardiac glycosidePeruvosideacute myeloid leukemia
spellingShingle Qian Feng
Wa Seng Leong
Liang Liu
Wai-In Chan
Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death
Molecules
cardiac glycoside
Peruvoside
acute myeloid leukemia
title Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death
title_full Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death
title_fullStr Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death
title_full_unstemmed Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death
title_short Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death
title_sort peruvoside a cardiac glycoside induces primitive myeloid leukemia cell death
topic cardiac glycoside
Peruvoside
acute myeloid leukemia
url http://www.mdpi.com/1420-3049/21/4/534
work_keys_str_mv AT qianfeng peruvosideacardiacglycosideinducesprimitivemyeloidleukemiacelldeath
AT wasengleong peruvosideacardiacglycosideinducesprimitivemyeloidleukemiacelldeath
AT liangliu peruvosideacardiacglycosideinducesprimitivemyeloidleukemiacelldeath
AT waiinchan peruvosideacardiacglycosideinducesprimitivemyeloidleukemiacelldeath